Titlebook: Cancer of the Oesophagus; Hugoe R. Matthews,John A. H. Waterhouse,Christophe Book 1987 The Authors 1987 biopsy.cancer.cancer registry.carc

弄碎

書目名稱Cancer of the Oesophagus影響因子(影響力)




書目名稱Cancer of the Oesophagus影響因子(影響力)學科排名




書目名稱Cancer of the Oesophagus網(wǎng)絡公開度




書目名稱Cancer of the Oesophagus網(wǎng)絡公開度學科排名




書目名稱Cancer of the Oesophagus被引頻次




書目名稱Cancer of the Oesophagus被引頻次學科排名




書目名稱Cancer of the Oesophagus年度引用




書目名稱Cancer of the Oesophagus年度引用學科排名




書目名稱Cancer of the Oesophagus讀者反饋




書目名稱Cancer of the Oesophagus讀者反饋學科排名

Abbreviate

International Studies in Entrepreneurshipte the ‘.’ group, consisting of patients who had intubation or by-pass for dysphagia, exploratory surgery or treatment directed only at metastases, together with those who had no initial treatment at all.

率直

Treatment,te the ‘.’ group, consisting of patients who had intubation or by-pass for dysphagia, exploratory surgery or treatment directed only at metastases, together with those who had no initial treatment at all.

防止

Histology,y are considered as a separate group in Chapter 7. The remaining cases are then analysed with respect to numbers and incidence rates for the different histological categories, by site and sex, for individual years, for quinquennia and for the age of the patient.

針葉

Overall Survival,cluding the 22 atypical tumours that occurred during this period). Survival rates have been calculated according to the method described in Chapter 1 (and in Appendix 2) and analysed with respect to histology, age, site, sex and quinquennium. The five cases of mixed adeno-squamous tumour are exclude

Fresco

Treatment,nitial diagnosis, or subsequently. Therefore in order to simplify the situation this analysis is confined to the treatment given at the time of first presentation and the main groups have been defined according to what the treatment was intended to achieve. Patients who had therapy which was intende

Fresco

Survival after Treatment,patients who received primary anti-tumour treatment and detailed survival data is given for curative and palliative treatments, and surgical resection specifically, by sex, site, histology, node status and age. Two-year survival data for the no primary anti-tumour treatment group is given in Table 6

lethal

Cancer of the Oesophagus978-1-349-09074-7Series ISSN 0954-7495 Series E-ISSN 2946-8345

諷刺滑稽戲劇

0954-7495 Overview: 978-1-349-09076-1978-1-349-09074-7Series ISSN 0954-7495 Series E-ISSN 2946-8345

Kindle